About Doc Generici
DOC Generici was founded in 1996 and is based in Milan, Italy. Operations focus on the generic pharmaceuticals sector, with specialization in ophthalmology. Treatments for macular degeneration, dry eye, glaucoma, and related eye conditions are developed and produced. The company serves the Italian market as a key player in these fields, emphasizing accessible healthcare solutions.
- Headquarter Milan, Italy
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Doc Pharma
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Doc Generici
Unlock access to complete
Funding Insights of Doc Generici
Investors in Doc Generici
Doc Generici has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include CVC, ICG and Charterhouse Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are managed by Charterhouse Capital Partners.
|
Founded Year | Domain | Location | |
|
Mezzanine financing and equity investments are provided by CVC.
|
Founded Year | Domain | Location | |
|
ICG is recognized as a global alternative asset manager.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Doc Generici
Financial Statements - Doc Generici
Doc Generici Comparisons
Competitors of Doc Generici
Frequently Asked Questions about Doc Generici
Doc Generici was founded in 1996.
Doc Generici is headquartered in Milan, Italy. It is registered at Milan, Lombardy, Italy.
Gualtiero Pasquarelli is the current CEO of Doc Generici.
DOC Generici was founded in 1996 and is based in Milan, Italy. Operations focus on the generic pharmaceuticals sector, with specialization in ophthalmology. Treatments for macular degeneration, dry eye, glaucoma, and related eye conditions are developed and produced. The company serves the Italian market as a key player in these fields, emphasizing accessible healthcare solutions.
Doc Generici has 4 investors. Key investors include CVC, ICG, Charterhouse Capital Partners, and Merieux Equity Partners.